Back to results
US 2017/0281531 A1Published application
Cranial delivery of pharmaceuticals
AssigneeGlia, LLC
InventorsKenneth I. Sawyer, Wei-wei Chang
Life of this patent
Estimating the term…
Abstract
A method for rapid delivery of an active compound to innervate a cranial nerve of a subject. Also provided is a method for treating a disease or condition by topically applying a pharmaceutical composition to the face excluding the palpebral part of the eye, in an amount effective for treating the disease or condition.
Claims20
A method for treating an ophthalmic disease or condition, the method comprising:
- identifying a subject having the disease or condition, and
- administering topically a topical progesterone composition to an area of the face of the subject not including the palpebral part of the eye,
- wherein the ophthalmic disease or condition is selected from the group consisting of ocular inflammation, ocular allergy, ocular tissue damage, ocular redness, allergic conjunctivitis, corneal damage, eye discomfort resulting from iatrogenic causes, blepharitis, meibomian cyst, uveitis, punctate keratitis, retinitis, vision problems associated with dyslexia, Sjogren's syndrome, and ocular pain.
A method for treating dyslexia, the method comprising:
- identifying a subject having dyslexia, and
- administering topically a topical progesterone composition to an area of the face of the subject not including the palpebral part of the eye.
A method for reducing behavioral and psychological symptoms associated with dementia, the method comprising:
- identifying a subject having behavioral or psychological symptoms associated with dementia, and
- administering topically a topical cannabinoid composition to an area of the face of the subject not including the palpebral part of the eye.
Dependencies are inferred from the claim text.